HPV E7 Biomarker Detection Kit

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

A fluorescent PCR melting curve method-based detection kit for genotyping Human Papillomavirus through E6/E7 mRNA analysis. This kit enables molecular diagnostics of HPV infections at the mRNA level.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

Real-time PCR kit for detection and genotyping of HPV E6/E7 mRNA in clinical specimens. Enables rapid identification of high-risk HPV types through multiplex amplification technology, supporting cervical cancer screening and risk stratification in molecular diagnostics laboratories.

Multiplex real-time PCR kit for simultaneous detection and genotyping of human papillomavirus (HPV) E6/E7 mRNA targets. Enables identification of multiple HPV genotypes in a single reaction, supporting cervical cancer screening and risk stratification in clinical laboratories.

Molecular diagnostic test for detection and genotyping of human papillomavirus. Supports cervical cancer screening and HPV-related disease diagnosis.

Real-time PCR assay for high-risk HPV detection and screening. Supports cervical cancer prevention through HPV risk assessment.

Multiplex real-time PCR kit for simultaneous detection and genotyping of 28 HPV types. Enables comprehensive cervical cancer screening and risk stratification through E6/E7 mRNA analysis. Delivers rapid, multiplexed results for clinical HPV surveillance and patient management.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

Molecular diagnostic test for human papillomavirus detection using polymerase chain reaction technology. Enables nucleic acid-based identification of HPV pathogens for clinical screening applications.

A diagnostic test kit for the detection of human papillomavirus (HPV) nucleic acids. The kit detects 18 types of HPV including 14 high-risk types recognized by the WHO that can lead to cervical cancer, as well as 4 medium-risk types identified by authoritative research as potentially related to cervical cancer. It uses hybridization capture and chemiluminescence methodology.

Molecular test for human papillomavirus detection and screening. PCR-based detection for cervical cancer risk assessment.